Analyst Profile

Followed by 3,756 followers
.
Yi Chen

Yi Chen

H.C. Wainwright
Wall Street Analyst
#8,082 out of 8,160 Wall Street Analysts
#24,013 out of 24,427 experts

Success Rate

22%
82 out of 376 transactions made a profit

Average Return

-32.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Yi Chen's trades since 2014 and holding each position for 1 Year would result in 21.81% of your transactions generating a profit, with an average return of -32.4% per rating.

Stock Rating Distribution

962Ratings
90.02% Buy
9.98% Hold
0.00% Sell
Distribution of Yi Chen's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
GermanyGermany Market
United KingdomUK Market

Best Rating

Stock:
Sensus Healthcare, Inc.
(SRTS)
Rating:Buy
Date:Aug 06, 2021 - Aug 06, 2022
Return:+301.90%
The most profitable rating made by Yi Chen

Yi Chen's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Trip.com Group Ltd. Sponsored ADR
Aug 01, 2014
Hold
Downgraded
$66.00
(107.09% Upside)
3Ratings
0.00%
Erin Energy
Sep 30, 2014
Buy
Reiterated
$9.00
(899999900.00% Upside)
1Ratings
0.00%
Arcturus Therapeutics
Nov 17, 2014
Hold
Downgraded
1Ratings
0.00%
Societal CDMO
Dec 09, 2014
Hold
Downgraded
1Ratings
0.00%
SCLN
Sciclone Pharmaceuticals
Dec 19, 2014
Buy
Reiterated
1Ratings
0.00%
LadRx
Jan 23, 2015
Buy
Reiterated
$12.00
(6389.99% Upside)
3Ratings
0.00%
STML
Stemline Therapeutics
Apr 27, 2015
Buy
Initiated
1Ratings
0.00%
InspireMD
Jan 07, 2016
Buy
Initiated
$4.00
(220.00% Upside)
1Ratings
0.00%
Lisata Therapeutics
Jan 08, 2016
Hold
Downgraded
4Ratings
0.00%
NRXGQ
NephroGenex
Jan 22, 2016
Buy
Reiterated
2Ratings
0.00%
List of latest recommendations made by Yi Chen. Click to expand and see Yi Chen's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >